Britain’s ‘fattest man’ – who weighs 47 STONE and eats up to 10,000 calories a day – fears he will die unless he gets miracle weight loss jab

Britain’s ‘fattest man’ fears he will die unless he urgently gets the ‘game-changer’ slimming jab Wegovy. 

Jason Holton, 33, from Camberley in Surrey, has been housebound for eight years because of his 47st frame. He lives in a custom-built council bungalow fitted with specially reinforced furniture

In 2020, he collapsed and had to be airlifted by crane from his mother’s third floor flat by a team of more than 30 firemen and engineers. 

But Mr Holton, who can consume up to 10,000 calories a day, has now said ‘time’s over for me’. Without Wegovy, he believes he will be dead within two years. 

While he is on the NHS waiting list, Mr Holton has been given no indication when he may begin using the jab, proven to suppress appetite and help people slim. 

He told TalkTV today: ‘I believe time’s over for me in general. I’m coming up 34 now. I know I’ve got to try something.’

At his peak, he weighed more than 50st and dubbed himself ‘Britain’s fattest man’. 

He is deemed too heavy for a gastric band.

Last month Brits could begin accessing Wegovy via specialist weight-management services as part of a ‘controlled and limited launch’ on the NHS. 

When it is fully rolled out it could help up to 50,000 patients lose weight.

But Mr Holton added: ‘Make it a priority for people that really need it — that really need it. 

‘Not people that are just chubby or obese, because I don’t feel that’s the problem.’ 

Since its launch, tens of thousands have already joined waiting lists for pharmacies which are receiving stocks of the drug to sell through online doctor services. 

Semaglutide — the powerful ingredient behind weight loss medications Ozempic and Wegovy — has ushered in a new era in the war on obesity. 

Trials show that semaglutide can help users lose up to 33lbs or 15.3kg on average in 68 weeks or around 12 per cent of their body weight. 

Under the NHS only Brits with a body mass index (BMI) over 30, or a BMI of more than 27 and at least one weight-related illness, are eligible — and patients must also commit to dieting and exercise plans. 

Over the past year however there has been a rise in off-label prescribing of Ozempic which contains a lower dose of the ingredient than Wegovy but has been available in the UK for diabetes patients since 2019. 

This fuelled shortages of the medication and led the Government to order the NHS and private clinics to stop prescribing the jabs to new patients over shortage concerns.

Mr Holton, who is totally immobile and struggles to breathe, believes he has now dropped to 47st but has no way to be sure because doctors can’t get him on the scales. 

During his most recent hospital visit, clinicians considered taking him to London Zoo to use their scanning equipment.

In 2020 he collapsed and had to be airlifted by crane from his mother’s third floor flat by a team of more than 30 firemen and engineers.

He said in the full interview, available on Talk Today: ‘That was the most devastating time of my life. The terrifying part of it all was the amount of people outside.’

Last year also he suffered a series of mini strokes and a suspected blood clot.

It took two hours to get him to Frimley Park Hospital in a specially-designed ambulance after his huge frame put immense pressure on his internal organs.

Mr Holton is believed to have become the UK’s fattest man after 65st Carl Thompson died in 2015.

Mr Holton’s health problems mean he is unable to work, leaving him on benefits.  

It is estimated his healthcare has cost the taxpayer hundreds of thousands of pounds.

He attributes bullying at school and mental health problems as the root cause of his weight gain. 

The death of his father when he was just three years old also had a profound impact, he said.

He told TalkTV: ‘Maybe if I had my father around, maybe there would be rules set to what I’m eating and stuff to stop me putting things and stuff in my mouth.

‘Just eating constantly. Lamb. doner meat, I had a problem with energy drinks. I just decided to get 15 of the Monster cans and drink them all in one go.’

But he insisted he has cut down and is eating healthier but it is having little impact,

He said: ‘I’ve been making changes which I seriously have for the audience by the way I have been, my diet now it’s not consistent of loads of junk and I’m not changing.’

By 2025, ‘I could be dead for sure, it’s a timebomb now,’ he added. 

Wegovy costs the standard prescription rate of £9.65. 

But many will not pay the prescription charge because the eligibility for the drug includes an existing illness, according to the health service.

People are entitled to free prescriptions if they meet one or more exemption categories. 

The jab could cost between £199 and £299 for those with private insurance or paying out of their own pocket. 

Last month, the Mail revealed that fake Ozempic was being sold in dozens of countries, and in one case contained insulin. If too much insulin is injected into the body, blood sugar can drop to fatally low levels in seconds.

Pharmacists have warned people to not buy weight-loss jabs such as Ozempic online over concerns they could cause serious harm and ‘damage major organs’.

The National Institute for Care and Excellence (NICE), which publishes heath guidelines, has advised that patients should only use Wegovy for a maximum of two years. 

This is despite experts saying people will need to take the drug for life. 

Semaglutide, the key ingredient in Ozempic and Wegovy, spurs weight loss by mimicking the actions of the hormone GLP-1, which is released in the gut after eating.

As well as telling the pancreas to make more insulin, GLP-1 tells the brain that users feel full.

However, it is not without side-effects. Users commonly complain of nausea, constipation and diarrhoea after taking the medication. 

A lack of exercise, combined with unhealthy diets, has been blamed for the growing obesity epidemic in the UK. 

Latest NHS data shows 26 per cent of adults in England are obese and a further 38 per cent are overweight but not obese. 

A landmark study published in May revealed the UK’s bulging waistline is stripping billions of pounds from the cash-strapped NHS each year, with twice as much spent on obese patients as on those of a healthy weight.

Costs per patient rise drastically the more people weigh, as they ‘collect obesity-related conditions’ such as type 2 diabetes, cancer and heart disease, according to research involving nearly 2.5million people.